| 000 | 00906 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250518065942.0 | ||
| 264 | 0 | _c20200601 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1935-469X | ||
| 024 | 7 |
_a10.1200/JOP.19.00445 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMangla, Ankit | |
| 245 | 0 | 0 |
_aRelevance of Anti-Galactose-α-1,3-Galactose Antibodies in the Era of Monoclonal Antibodies. _h[electronic resource] |
| 260 |
_bJournal of oncology practice _c12 2019 |
||
| 300 |
_a679-680 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 | _aAntineoplastic Agents, Immunological |
| 650 | 0 | 4 | _aGalactose |
| 650 | 0 | 4 | _aIncidence |
| 700 | 1 | _aAgarwal, Nikki | |
| 773 | 0 |
_tJournal of oncology practice _gvol. 15 _gno. 12 _gp. 679-680 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JOP.19.00445 _zAvailable from publisher's website |
| 999 |
_c30279947 _d30279947 |
||